Could microdosing Ozempic or acne pills work BETTER and cut your risk of side-effects?
Could taking tiny fractions of the normal prescribed dose of a medication offer a brilliant way to benefit from the drug, ...
AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal
Key Takeaways AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra.AbbVie said it will ...
Amazon-backed AI firm Anthropic valued at $61.5 billion after latest round
Anthropic on Monday closed its latest funding round at a $61.5 billion post-money valuation, the company confirmed to CNBC.
Campaign US17h
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’
Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...
WFYI18h
Indiana joins states calling for the FDA to clamp down on counterfeit weight loss drugs
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...
The UK18h
Medical device firm secures investment to accelerate global expansion
A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...
BioSpace19h
Obesity Late-Comer AbbVie Inks Up to $2.2B Amylin Deal With Gubra
AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...
Novo Nordisk Launches National "My Ozempic® Era" Campaign Celebrating Stories of Inspirational Ozempic® Patients
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...